Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API). The Company is the store brand manufacturer of OTC pharmaceutical products and infant formulas. The Company has four segments, aligned primarily by type of product: Consumer Healthcare, Nutritionals, Rx Pharmaceuticals and API. In addition, the Company has an Other category that consists of the Israel Pharmaceutical and Diagnostic Products operating segment. In February 2013, it completed the acquisition of Leeds, United Kingdom-based Rosemont Pharmaceuticals Ltd. In April 2013, it closed the acquisition of Velcera, Inc.